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Abstract
The innate ability of the human cell to silence endogenous retroviruses through RNA sequences encoding microRNAs,
suggests that the cellular RNAi machinery is a major means by which the host mounts a defense response against present
day retroviruses. Indeed, cellular miRNAs target and hybridize to specific sequences of both HTLV-1 and HIV-1 viral
transcripts. However, much like the variety of host immune responses to retroviral infection, the virus itself contains
mechanisms that assist in the evasion of viral inhibition through control of the cellular RNAi pathway. Retroviruses can
hijack both the enzymatic and catalytic components of the RNAi pathway, in some cases to produce novel viral miRNAs that
can either assist in active viral infection or promote a latent state. Here, we show that HTLV-1 Tax contributes to the
dysregulation of the RNAi pathway by altering the expression of key components of this pathway. A survey of uninfected
and HTLV-1 infected cells revealed that Drosha protein is present at lower levels in all HTLV-1 infected cell lines and in
infected primary cells, while other components such as DGCR8 were not dramatically altered. We show colocalization of Tax
and Drosha in the nucleus in vitro as well as coimmunoprecipitation in the presence of proteasome inhibitors, indicating
that Tax interacts with Drosha and may target it to specific areas of the cell, namely, the proteasome. In the presence of Tax
we observed a prevention of primary miRNA cleavage by Drosha. Finally, the changes in cellular miRNA expression in HTLV1 infected cells can be mimicked by the add back of Drosha or the addition of antagomiRs against the cellular miRNAs
which are downregulated by the virus.
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cellular invaders such as pathogens and viruses. In a host cell,
miRNAs are the product of the RNA interference (RNAi)
pathway, a regulatory and innate defense mechanism that is
conserved in eukaryotes. This pathway utilizes short non-coding
RNA sequences of 18–21 nucleotides to bind to mRNA
sequences with complementary homology, subsequently restricting the translation of these transcripts [9]. Following RNA Pol
II transcription of a gene, the Pri-miRNA consists of a series of
RNA hairpins protruding from an RNA message with a 59cap
and poly-A tail. This Pri-miRNA is cleaved by a microprocessor
complex of nuclear proteins, Drosha, an RNase II endonuclease, and DCGR8 (Pasha), an RNA-binding protein, to form a
stem and loop RNA-structure called Pre-miRNA. This PremiRNA is shuttled out of the nucleus into the cytoplasm via
Exportin5 and is further processed by an additional RNase III
enzyme, Dicer, which cleaves the hairpin into a short miRNA
duplex. These miRNA then associate with the RNA induced
silencing complex (RISC), composed of Ago2 and TRBP

Introduction
Human T-lymphotropic virus type 1 (HTLV-1) was originally
discovered in 1980, identified as the first human retrovirus, and
currently infects more than 20 million people worldwide [1–5].
HTLV-1 is the etiologic agent of adult T-cell leukemia/lymphoma
(ATLL) and HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) in infected individuals. Oncogenesis is
due primarily to the viral transactivator protein, Tax, a 40-kDa
phosphoprotein that regulates not only viral transcription, but acts
to manipulate host cellular functions such as cell cycle progression,
apoptosis, chromatin remodeling, and other signal transduction
pathways [6–8]. Recently, much interest has developed in
elucidating the cross-talk between tumor development and
HTLV-1 infection as it relates to the innate host response, in
particular the small RNA regulatory network.
Human microRNA (miRNA) sequences derived from the
genome have the ability to silence cellular genes and are
currently considered a primary host immune defense against
PLoS ONE | www.plosone.org
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proteins, which then aids in miRNA-mediated target recognition. This guide effector protein complex assists in either
degrading the targeted message or preventing its translation
[10]. The dysregulation of this pathway is highly evident across
a variety of cancers and viruses, including HIV-1, HTLV-1,
Influenza, HCV, Ebola, Vaccinia, PFV-1, LACV, Adenovirus,
and SARS-CoV although the mechanisms of action for most of
these viruses remains to be determined [11–27]. Indeed, cellular
miRNAs are able to silence endogenous retroviruses, sequences
which typically share a high degree of homology to present day
retroviruses, such as HTLV-1 and HIV-1.
HTLV-1 Tax acts to transactivate the viral long terminal
repeat (LTR) through Tax-responsive elements (TREs) in the
U3 region. This occurs through transcriptional induction of
TREs, posttranslational modifications of TRE-binding factors,
and binding with transcription factors. Tax is known to interact
with the transcription factors CREB, serum-responsive factor
(SRF), and NF-kB as well as with the cell cycle related proteins
Cyclin D2 and D3, mitotic checkpoint regulators (MAD1),
cyclin-dependent kinases (cdks), cdk inhibitors p16INK4a and
p21/waf1, and p53 [5,28–43]. Phosphorylation of Tax is
necessary for Tax localization in nuclear bodies as well as
activation of cellular gene expression through the NF-kB
pathway. Tax activates HTLV-1 transcription through CREB
and three CRE enhancer sequences on the LTR. Tax also
interacts with CBP/p300, which is involved in the formation of
the preinitiation complex as well as the p300/CBP-associated
factor, P/CAF, which also plays a role in active HTLV-1 gene
transcription [37,44–46]. Taken together, HTLV-1 Tax is
heavily involved in direct interactions with critical cellular
proteins that control not only viral gene expression but also
cellular genes involved in tumor formation.
We have previously shown that Tax interacts directly with
the cellular Rb (Retinoblastoma) protein and targets Rb for
degradation via the proteasome pathway, resulting in a decrease
in Rb protein expression in HTLV-1 infected cells and a
dysregulation of the cell cycle [47]. Due to the nature of Tax to
manipulate and control cellular proteins such as Rb and overall
cell cycle progression, we became interested in determining the
effect of HTLV-1 infection and Tax expression on other cellular
proteins regulating oncogenesis, including the RNAi pathway.
HTLV-1 encodes an additional regulatory protein, called Rex,
which has recently been implicated in having RNA silencing
suppressor activity. Specifically, Rex interacts with both RNA
and Dicer, suppressing Dicer’s enzymatic activity [15]. Recently,
Tax has been shown to specifically mediate the downregulation
of cellular miRNAs which are associated with the regulation of
chromatin remodeling factors [48]. Specifically, Tax downregulated miR-149 and miR-873, both of which directly target
p300 and P/CAF [48]. This suggests that HTLV-1 infection
and its viral transactivators may play a role in dysregulation of
the RNAi pathway. Here we show that HTLV-1 infection in
the presence of Tax, significantly downregulates Drosha protein
expression. We show the in vitro interaction between Tax and
Drosha, both in the nucleus and in complex in the presence of
proteasome inhibitors. We observe a downregulation of Drosha
functionality in the presence of Tax as measured by primary
miRNA cleavage. Finally, the changes in cellular miRNA
expression in HTLV-1 infected cells can be mimicked in
uninfected cells supplementing excess functional Drosha or the
addition of antagomiRs against the cellular miRNAs which are
downregulated by the virus.

PLoS ONE | www.plosone.org

Results
HTLV-1 Downregulates Core Components of the RNAi
Machinery
Tax acts as the HTLV-1 viral transactivator protein by
interacting with various cellular and viral proteins including
transcription factors, kinases, and chromatin remodeling proteins,
ultimately altering cellular pathways such as apoptosis and the cell
cycle to control viral replication and oncogenesis [6–8]. Recently,
retroviruses have been shown to control the cellular RNAi
pathway in order to evade viral inhibition and also to hijack both
the enzymatic and catalytic components of the miRNA machinery. This viral response assists in promoting an active viral
infection, or a latent state of infection [11,48–49]. Indeed, other
retroviruses such as HIV-1 have been shown to impart a specific
suppression of Dicer expression in monocyte-derived-macrophages as compared to T-cells [50]. In order to examine the role
HTLV-1 infection has on possible control of the RNAi pathway,
we initially screened for the protein levels of core components of
the RNAi machinery in HTLV-1 infected cells as compared to
uninfected cells. Total protein levels of Drosha, DGCR8, Dicer,
Ago2, and b-Actin were detected in three uninfected T-cell lines,
H9, Jurkat, and CEM, as well as in three HTLV-1 infected, Taxpositive T-cell lines, C81, MT2, and MT4 (Figure 1A, lanes 1–3
and lanes 4–6). Drosha protein levels were significantly downregulated in all of the HTLV-1 infected, Tax-positive cells tested
when compared to the uninfected cells. Specifically, Drosha is
decreased by 62.6% in C81 cells, 97.3% in MT2 cells, and 91.5%
in MT4 cells when compared to CEM cells (normalized to bActin). Dicer protein was also slightly downregulated in C81 cells,
but more so in MT2 cells when compared to CEM cells
(normalized to b-Actin). Conversely, DGCR8 and Ago2 showed
no significant changes in protein level amongst all cell lines
screened, suggesting that the downregulation seen for Drosha and
Dicer is specific and not a consequence of the entire pathway
being inhibited. Interestingly, the protein levels of the core
components of the RNAi machinery were also detected in two
HTLV-1 infected, Tax-negative cell lines (Figure 1A, lanes 7, 8).
Drosha was downregulated by 77.1% in MT1 cells and 51.3% in
ED- cells as compared to CEM cells (normalized to b-Actin). We
titrated both MT1 and ED- cells in order to determine if this
downregulation was an artifact and indeed, with increasing
concentrations of protein extract (50, 75, and 100 mg), Drosha
levels also increase (Figure 1B), suggesting that the relative
decrease in Drosha is less in HTLV-1 infected, Tax-negative cells
as compared to Tax-positive cells. We reproduced these results in
HTLV-1 infected CD4+ primary T-cells (Figure 1C), where
Drosha levels are dramatically downregulated as compared to
uninfected cells (lane 2 compared to lane 1). In order to rule out
the possibility that the loss of Drosha protein is due to a decrease in
transcript levels, we performed an RT-PCR of total mRNA
isolated from CEM, MT2, ED-, and MT1 cells for Drosha
transcripts. In Figure 1D, we show that the Drosha transcript
levels are unchanged as compared to GAPDH across all four of
these cell lines.
Next, we attempted to mimic this downregulation of Drosha
and Dicer by introducing both Tax and HTLV-1 into uninfected
293T cells and screening for core RNAi machinery components.
293T cells were transfected with three concentrations (0.1, 1.0,
10 mg) of plasmids expressing pACH (full-length HTLV-1 clone),
pcTax, pACH.M22 (mutated tax gene), or an empty vector
control. The pACH.M22 plasmid contains a double amino acid
substitution at positions 130 and 131 and eliminates the ability of
Tax to transactivate the NF-kB pathway [51–54]. Cells were
2
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Figure 1. The RNAi machinery is dysregulated with HTLV-1 infection. A) Uninfected (H9, Jurkat, CEM), HTLV-1 infected, Tax-positive (C81,
MT2, MT4), and HTLV-1 infected, Tax-negative (ED-, MT1) T-cell lines were screened for endogenous protein levels of Drosha, DGCR8, Dicer, and Ago2.
Seventy-five micrograms of total lysates were used for western blots. Multiple bands for DGCR8 are indicative of isoforms at 86 and 65 kDa. b-Actin
serves as a loading control. B) Total lysates of HTLV-1 infected, Tax-negative cell lines ED- and MT1 were titrated (50, 75 and 100 mg) and screened for
endogenous protein levels of Drosha, DGCR8, Dicer, and Ago2. Multiple bands for DGCR8 are indicative of isoforms at 86 and 65 kDa. b-Actin serves
as a loading control. C) Whole cell lysates (50 mg) from HTLV-1 infected primary CD4+ T-cells were run on a 10% Tris-glycine SDS-PAGE gel and
western blotted for Drosha. Data is representative of three independent experiments. b-Actin serves as a loading control. D) Total RNA was isolated
with TRIzol from CEM, MT2, ED-, and MT1 cell lines. RT-PCR was performed for cellular Drosha transcript levels. GAPDH serves as a housekeeping gene
loading control. E) Uninfected 293T cells were transfected with pcDNA (0.1, 1.0, and 10 mg), pACH (0.1, 1.0, and 10 mg), pcTax (0.1, 1.0, and 10 mg), or
pACH.M22 (0.1, 1.0, and 10 mg) and were screened for protein levels of Drosha, Dicer, Ago2, Ago1, and Tax. Seventy-five micrograms of total lysates
was used for western blots. b-Actin serves as a loading control. F) Total RNA was isolated with TRIzol from the transfected cells in panel E. RT-PCR was
performed for cellular Drosha transcript levels. GAPDH serves as a housekeeping gene loading control.
doi:10.1371/journal.pone.0040662.g001

collected 48 hours post-transfection and were western blotted for
the presence of Drosha, Dicer, Ago2, Ago1, Tax and b-Actin.
Figure 1E shows endogenous protein levels of core RNAi
machinery components in 293T cells transfected with pcDNA
and other vectors. Comparing Drosha proteins levels in cell
expressing pACH, pcTax, and pACH.M22 to the pcDNA control
(lanes 6, 7, 8 and 9, 10, 11 and 12, 13, 14 to lanes 2, 3, 4,
respectively) results in a 27.5% decrease in pACH (10 mg)
expressing cells (lane 8), a 67.3% decrease in pcTax (10 mg)
expressing cells (lane 11) and only a 10.4% decrease in
pACH.M22 (10 mg) expressing cells. These results imply that in
the pACH.M22 mutant Tax expressing cells, we observe close to
endogenous levels of Drosha, indicating the downregulation of
Drosha may be the result of a functional Tax. Overall, relative
expression levels of Dicer, Ago2, and Ago1 reproduce the data
from Figure 1A. The Tax western blot serves as a positive control
for Tax expression (lanes 2 and 6–14). The b-Actin western serves
as a positive loading control. Again we confirmed that this
decrease in Drosha protein levels is due to Tax expression and not
due to an effect on total transcript levels (Figure 1F). Collectively,
these data indicate that HTLV-1 infection in the presence of Tax
downregulates the RNAi enzyme Drosha in chronically infected
cell lines, transfected cells, and primary cells infected with HTLV1 virus.

Drosha is Found in Complex with Tax
The full length Tax protein contains a variety of domains that
impart specific protein-protein interactions as well as interactions
with sub-cellular components. The N-terminus of Tax contains
both a nuclear localization signal (NLS) as well as a zinc-finger
domain which is involved with interactions with cellular
transcription factors [31,49,55–57]. Specifically, this domain of
Tax is responsible for Tax-mediated CREB transactivation. The
C-terminus of Tax is responsible for nuclear-cytoplasmic shuttling
and contains a Golgi localization motif, a secretion motif, an
LXCXE-like motif, and a PDZ-binding domain [5,47,58–64].
Additionally, the region of Tax between the N- and C-termini
includes two leucine zipper motifs used for dimerization as well as
activation of NF-kB [5,58–61]. We have previously shown that
Tax is capable of binding to cellular Rb via its LXCXE-like motif
[47]. To identify the domain of Tax that binds to Drosha, we
performed an in vitro binding assay using full-length Tax and
various fragments covering the entire Tax protein fused to GST.
Figure 3A shows the results of a GST-Tax pulldown from HeLa
whole cell extracts, followed by a western blot for the presence of
Drosha. Drosha bound to wild type Tax, but much stronger
binding was observed at the N-terminal domain that contained
sequence 1–244. This is partly because the C-terminus may fold
back and contain inhibitory activity in an in vitro binding assay. We
have also confirmed the interaction of Tax and Drosha in vitro with
an immunoprecipitation (IP). We transfected 293T cells with the
HTLV-1 clone pACH.Tax (5 mg) or pACH.M22 (5 mg) mutant
Tax in the presence of the proteasome inhibitor PSI (10 mM). Our
rational for using a proteasome inhibitor was to be able to isolate
complexes that were available for biochemical analysis prior to the
targeted degradation via the proteosome pathway. We collected
cells 48 hours post transfection and lysed whole cell extracts
(,1 mg) for an overnight IP with a-Tax, a-Drosha, or a-IgG
antibodies. The following day, Protein A + G beads were
incubated with the extracts for 2 hours, the beads were washed
with low salt buffer, proteins eluted in Laemmli buffer, and were
subsequently western blotted for the presence of Drosha. As shown
in Figure 3B, Drosha can be successfully IPed out of cells
expressing wild type Tax with a-Tax in the presence of a
proteasome inhibitor (lane 5). 293T cells alone serve as a positive
control for the Drosha western blot (lane 1) as well as a positive
control for the Drosha IP/western blot (lane 3). Interestingly, the
mutant ACH.M22 Tax is unable to interact with Drosha (lane 7).
This Tax mutant is only faintly ubiquitinylated and can’t interact
with the proteasome, therefore indicating that the interaction of
Tax and Drosha and the subsequent degradation requires
interaction with the proteasome [65]. The a-Drosha antibody
used for the western blot recognizes all three isoforms of Drosha,
corresponding to the molecular weights of 170, 156, and 115 kDa,
which accounts for the multiple Drosha bands. However, the
strongest Tax binding is to the 170 kDa form. A ubiquitin western

Colocalization of Tax with Drosha in the Nucleus
The viral protein Tax has been well documented as interacting
directly with multiple critical cellular proteins that control
oncogenesis. We sought to determine whether or not Tax interacts
with Drosha in order to downregulate and/or signal the Drosha
protein for possible degradation. To investigate the potential
interaction of Tax and Drosha, we transfected pcTax into HeLa
cells and stained the cells 48 hours post-transfection for confocal
imaging. We labeled both untransfected and Tax-transfected
HeLa cells with antibodies against BRG1, Drosha, Rb, GIT2, and
Tax. BRG1 and Rb serve as positive Tax-interacting proteins as
we have previously shown their intracellular interaction [1,47].
BRG1 is constitutively expressed in HeLa cells in the absence of
Tax, however post-Tax transfection, BRG1 is found almost
exclusively in the nucleus and colocalizes with Tax (Figure 2A).
Similarly, Rb is heterogeneously expressed in HeLa cells, however
colocalizes with Tax in the nucleus of Tax-expressing cells
(Figure 2D). Interestingly, in Tax expressing cells, Drosha is
almost exclusively found in the nucleus at specific foci colocalizing
with Tax (Figures 2B, C). In order to address possible nonspecific
shuttling between the nucleus and the cytoplasm due to
transfection conditions or overexpression of Tax, we utilized
GIT2 to serve as a negative control for a protein that does not
shuttle to the nucleus or colocalize in the presence of Tax
(Figure 2E). Therefore, our imaging data show that Tax and
Drosha colocalize in the nucleus of Tax-expressing cells.
PLoS ONE | www.plosone.org
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Figure 2. Nuclear colocalization of HTLV-1 Tax with cellular proteins. HeLa cells were grown on coverslips in the presence or absence of
HTLV-1 Tax. Forty-eight hours post transfection of pcTax (5 mg), cells were stained for BRG1 (A), Drosha (B, C), Rb (D), and GIT2 (E) and were
visualized with confocal microscopy. Cellular protein staining is represented in green, Tax staining in red, and yellow foci represent colocalization of
dual stained cells. Nuclei were stained with DAPI (blue). GIT2 serves as a cytoplasmic protein control.
doi:10.1371/journal.pone.0040662.g002

mechanism to decrease Drosha protein levels, we designed
experiments using proteasome inhibitors. We treated HTLV-1
infected C81 cells with proteasome inhibitors PSI and ALLN (0.1,
1.0, 10 mM). At 48 hours post-treatment, the cells were collected
and western blotted for the presence of Drosha. Figure 3D shows
the western blot of Drosha normalized to b-Actin. Both PSI and
ALLN treated cells showed an increase in Drosha protein levels
concurrent with increasing concentration of proteasome inhibitor.
Indeed, the 10 mM-treated cells show almost a 30% increase in
Drosha protein levels compared to C81 cells alone. All treated cells
exhibited no toxicity across three independent experiments (data
not shown). This data further indicates that Drosha protein levels

blot is included as an indication that Drosha is being ubiquitinated
in the presence of Tax, however, not in the presence of a Tax
mutant (compare lane 5 to lane 7). A summary of relative Drosha
binding affinity to Tax constructs from multiple experiments is
depicted in Figure 3C. Based on these data, Tax binds to Drosha
via the N-terminus (aa 1–244), given that the strongest binding was
shown to occur within this region, and can also be identified in
complex with Drosha. Collectively, these data indicate that Tax
and Drosha interact and can be found in complex in vitro.
Previously, we have shown that the binding of Tax and Rb
results in a targeted degradation of Rb via the proteasome
pathway [47]. To investigate whether Tax utilizes a similar

PLoS ONE | www.plosone.org
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Figure 3. HTLV-1 Tax interacts with Drosha in vitro. A) HeLa whole cell lysates (1 mg) were incubated with purified GST-fusion proteins (,5 mg)
bound to Glutathione-Sepharose beads: GST-Alone, GST-Tax wild type, GST-Tax N-terminus, 1–244, GST-Tax C-terminus, 244–336, and GST-Tax
truncated, 288–353. Beads were washed gently, proteins eluted, and western blotted for the presence of Drosha. CEM whole cell extract serves as a
positive Drosha control. B) 293T cell lysates were prepared from cells alone or cells transfected with pACH.Tax (5 mg) or pACH.M22 (5 mg) in the
presence of the proteasome inhibitor PSI (10 mM). Approximately 1 mg of lysate was incubated with a-IgG, a-Drosha, or a-Tax overnight at 4uC. The
next day, 50 ml of a 30% Protein A + G slurry was used to IP Drosha or Tax and subsequently western blotted for the presence of Drosha and
Ubiquitin. Multiple isoforms of Drosha as detected by the antibody are indicated as Drosha I (170 kDa), Drosha II (156 kDa), and Drosha III (115 kDa).
C) Graphical depiction of the GST-Tax constructs and the regions which they span for the Tax protein. Relative Drosha binding is based on
densitometry counts. D) C81 cells were treated with the proteasome inhibitors PSI and ALLN at increasing concentrations (0.1, 1.0, and 10 mM) for 48
hours. Cell lysates were western blotted for the presence of Drosha. b-Actin serves as a loading control. Drosha recovery as a percentage of CEM
Drosha levels is indicated from densitometry counts normalized to b-Actin using ImageJ.
doi:10.1371/journal.pone.0040662.g003

cells 48 hours post-transfection and isolated total RNA by TRIzol
extraction. The expression of miR326 was determined by the
quantiMiR PCR kit and is shown as a fold change in Figure 4A
normalized to U6 and relative to mock transfected control. This
data indicates that the Tax D1 mutant and the TaxD55 mutant
increase miR326 expression 1.5 and 4 fold, respectively, above
basal levels. Interestingly, the Tax mutants spanning from residue
99 to 353 have no functional implications for miR326 expression.
These mutants are as functional as the Tax WT, indicating that
these regions of deletion are not critical for Drosha function. The
significance of the Tax D1 and D55 mutants therefore implies that
the regions of Tax deleted in these mutants are necessary for
Drosha interaction as well as suppression of function. In order to
compare the increase in expression of miR326 to the overall
transcript levels in the cell, therefore ruling out non-specificity, we
detected primary transcripts encoding miR326 against a region
upstream of the miRNA hairpin. These values were normalized to
GAPDH and are shown in Figure 4B as a ratio of the relative level
of miRNA present over the relative level of primary transcript.
The mock transfected cells were set to 100% efficiency. This data
indicates an increase in Drosha efficiency of 100% over the mock
transfected cells with the Tax D1 mutant. The Tax WT vector
decreased Drosha functionality by 25% as compared to the

can be rescued from suppression by HTLV-1 infection with
proteasome inhibitors, suggesting that Drosha is targeted by Tax
to be degraded via the proteasomal pathway. Collectively, these
data point to the regulation of Drosha by direct binding to the Nterminus of Tax and further degradation by the proteasomal
pathway.

Tax Prevents Primary miRNA Cleavage by Drosha
We have shown that Tax and Drosha interact in vitro and that
this complex results in a downregulation/degradation of the
cellular Drosha protein. This suppression of Drosha is not
completely efficient however, as there is still some endogenous
Drosha remaining in HTLV-1 infected cells. Here we question
whether the remaining Drosha is functional in Tax expressing
cells. We utilized a system where we quantify levels of cellular
miR326 in Tax transfected cells normalized to a U6 control. We
then calculate Drosha functional efficiency as a measure of the
relative level of miRNA present versus the relative level of primary
transcript, where 100% is the rate of production in the control. To
this end, we transfected 293T cells with expression vectors (1 mg)
for wildtype Tax or the following iterative Tax deletion mutants:
TD1 (D1–37), TD55 (D55–92), TD99 (D99–142), TD150 (D150–
198), TD254 (D254–287), or TD319 (D319–353). We collected the
PLoS ONE | www.plosone.org
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infection results in a dramatic up (i.e. miR-130b, miR-18a, miR20b) and downregulation (i.e. Let-7i, miR-132, miR-199a) of
many host cellular miRNAs [67]. The modulation of these host
miRNAs has an effect on the expression of cellular proteins such as
p300, NF-kB, and BRM, to name a few, which are all recruited by
Tax and play a key role in activating HTLV-1 gene transcription
[5,30–36,38–40,44–45,56,60,68–71]. To better define the functional significance of Drosha downregulation by Tax, we
transfected 293T cells with pACH.Tax (5 mg) and 24 hours later
added back pGFP-Drosha (10 mg). The cells were collected 72
hours later and were lysed (50 mg) for western blots of the
corresponding downstream proteins, IKK-b, BRM, and b-Actin.
Here the rationale was that Tax would decrease Drosha levels,
resulting in downregulation of miRNA, such as Let7i, miR-199a3p and miR-132. Downregulation of these miRNAs would in turn
effect the translation of mRNAs for genes such as IKK-b and
BRM (possibly regulated by miR-199a-3p) and other proteins
important for HTLV-1 gene expression. Data in Figure 6A shows
that transfection of Tax downregulates both IKK-b and BRM as
compared to the control Drosha add back experiment (compare
Lanes 2 and 3). On the other hand, the evidence of Drosha
downregulation in the presence of Tax implies the downregulation
of cellular miRNAs in response to HTLV-1 infection and
subsequent increase in target protein expression. Of particular
interest are a set of cellular miRNAs, such as Let-7i, miR-199a-3p,
and miR-132 that are downregulated after infection, resulting in
an upregulation of cellular proteins that are known to be recruited
and utilized by the HTLV-1 promoter. In order to mimic the
effect Tax has on cells by sequestering the endogenous miR,
therefore allowing for the basal, unchecked expression of these
cellular proteins, we transfected 293T cells with either Tax or an
antagomiR against endogenous cellular miRs which are downregulated with HTLV-1 infection. AntagomiRs used include antihsa-Let-7i to target p50 and p65 miRNA, anti-hsa-miR-132 to
target GSK-3b miRNA, and anti-hsa-miR199a-3p to target IKKb and BRM miRNA. Cells were collected 72 hours post
transfection and western blots were performed for IKK-b, p65,
p50, GSK-3b, and b-Actin. Results in Figure 6B are shown as
densitometry counts of western blots for each indicated protein
normalized to b-Actin, plotted as a percent change (measured as
arbitrary counts) between antagomiR treated cells and 293T cells
alone. These results indicate that there was a dramatic increase of
protein expression of IKK-b, and p65 of approximately 300 and
250%, respectively. There was an approximate 10% increase in
protein levels of p50, GSK-3b and BRM upon antagomiR
treatment as compared to cells alone. Collectively, these data
indicate that proteins, such as IKK-b, among others, may directly
be regulated by the Tax/Drosha interaction in HTLV infected
cells.

control. It is interesting that the Tax D1 mutant increased the
efficiency of processing of Drosha 100%, however, only increased
the relative miR326 expression 1.5 fold. These two values are not
necessarily proportional as the extrapolation of an active,
functional Drosha in the presence of this mutant, does not
necessarily have to result in a direct effect on miR326. In Figure 4C
we represent a more detailed schematic of the binding domains
and motifs of Tax. We depict important binding and interactive
regions of Tax with brackets, including the numbered residues.
We also depict the cellular proteins with which Tax interacts
below each sequence of interest. We propose that Drosha is
binding to the N-terminus of Tax, however, more specifically to
the region of Tax from 1–92, depicted as the grey shaded area. We
have previously confirmed that Tax interacts with the proteasome
at residues 23–62, which is also the site of the NLS, Zn finger, as
well as the domain involved in CREB activation [47]. This data
agrees with the interactions of Tax and Drosha in Figure 3, where
the N-terminus of Tax is responsible for Drosha binding.
Collectively, these data indicate that the Drosha in Tax-containing
and HTLV-1 infected cells is mostly functionally inactive and the
functional suppression of Drosha is dependent on its interaction
with a small region of the N-terminus of Tax.

Loss of Drosha and DGCR8 Increases Viral Replication
We have shown above that Drosha is downregulated, degraded,
and mostly inactive in HTLV-1 infected cells, however, it was not
clear what effect this dysregulation of Drosha would have on viral
replication. Here we investigated whether loss of cellular Drosha
by siRNA knockdown could affect viral replication. In doing this,
it is important to distinguish between a Drosha-specific dysregulation as opposed to an overall disruption of the RNAi pathway,
therefore we used siRNA against other RNAi components as a
control. We transfected 293T cells with HTLV-1 infectious pACH
clone (5 mg), and 24-hours post transfection, with siRNAs against
Luciferase (150 nM), Drosha (50, 150, 300 nM), DGCR8 (50,
150, 300 nM), and Ago2 (50, 150, 300 nM). At 72hours posttransfection, we collected cell culture supernatants and assayed for
the presence of virus using an RT (reverse transcriptase) assay.
Results of such an experiment are shown in Figure 5A. Here we
observed that pACH clone was able to replicate well with the
highest concentration of siDrosha and even more dramatic results
were obtained with siDGCR8. Interestingly, the loss of DGCR8
across all three concentrations of siRNA resulted in a consistent
activation of viral replication. A knockdown of Ago2 did not result
in a significant increase in viral replication. Western blot
confirmation of the siRNA knockdowns are shown in Figure 5B.
In order to determine whether or not the inhibition of Ago2 would
result in a decrease in viral fitness and an inhibition of replication,
we adopted an alternative approach and treated 293T cells
transfected with pACH with the RISC/Ago2 inhibitor Acriflavine
(ACF) (0.1, 1.0, and 2.5 mM) [66]. At 72 hours post transfection,
we collected supernatants and assayed for the presence of virus via
RT assay. We observed that that the efficient, drug inhibition of
Ago2 function decreases viral replication at levels comparable to
siAgo2 transfection. Collectively, these data indicate that the loss
of Drosha and DGCR8 in HTLV-1 infected cells results in an
increase in viral replication and its release from the cell.

Discussion
HTLV-1 is an oncogenic retrovirus which targets and
manipulates common cellular tumor suppressors and signaling
pathways in order to establish and maintain a productive infection.
Recently, the role of miRNAs in both tumor development and
viral infections has provided evidence that the RNAi pathway itself
is also targeted by this virus. Indeed, all DNA tumor viruses, with
the exception of human papillomaviruses, encode viral miRNAs
which modulate tumorigenesis, therefore indicating that the
cellular RNAi regulatory pathway is important for viral pathogenesis and control. For example, Epstein Barr Virus (EBV)
encodes 25 viral miRNA precursors which are expressed
differentially amongst various stages of latency and act to suppress

Suppression of Cellular miRNAs by HTLV-1 can be
Rescued by Over Expression of Drosha and Mimicked by
antagomiRs
We were next interested in the regulation and downstream
effects of the RNAi pathway in HTLV-1 infected cells. HTLV-1
PLoS ONE | www.plosone.org
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Figure 4. Tax prevents primary miRNA cleavage by Drosha. 293T cells were transfected with Tax expression vectors (1 mg): Tax WT, TD1 (D1–
37), TD55 (D55–92), TD99 (D99–142), TD150 (D150–198), TD254 (D254–287), or TD319 (D319–353). A) Forty-eight hours post transfection, total RNA
was isolated by TRIzol extraction and expression of miR326 was determined by quantiMiR PCR kit using primers specific to miR326. Values shown are
normalized to U6 and shown relative to control. B) Primary transcripts encoding miR326 were detected by RT-qPCR against a region upstream of the
miRNA hairpin. Quantities were normalized to GAPDH and efficiency of Drosha processing was determined by charting the expression of mature
miRNA over the expression of the primary transcript. Data is shown with the efficiency in the control cells set to 100%. C) A graphical depiction of the
Tax mutant constructs TD1 and TD55 with deleted regions and the corresponding domains and motifs of full length Tax. The function of each domain
is indicated in brackets and arrows, as well as the associated interacting cellular proteins below each region. The proposed Drosha binding region is
indicated by the grey shaded box.
doi:10.1371/journal.pone.0040662.g004

has been shown to not only encode its own TAR (trans-activation
response region)-derived miRNA which acts as an RNAi decoy,
but it also utilizes the viral transactivator Tat as an RNAi
suppressor [14,21–22,76–80].
In this study, we characterize the effect HTLV-1 infection has
on the cellular RNAi pathway. We have demonstrated that
Drosha is downregulated in HTLV-1 infected cell lines, HTLV-1
transfected cells, and infected primary cells. We have also shown
that Dicer is downregulated in HTLV-1 infected cell lines only,
suggesting that this loss of Dicer could be due to a cell line specific
phenomenon and not so much HTLV-1 infection or early stage
replication.

chemokines, inhibit the viral DNA polymerase BALF5, and
downregulate the cellular protein PUMA (p53 upregulated
modulator of apoptosis) [72–75]. This complex interaction
network between viruses and the RNAi pathway can be best
described as reciprocal due to host cell miRNAs targeting both
cellular and viral transcripts as well as viral miRNAs targeting
both cellular and viral transcripts. Additionally, viruses can
produce RNA molecules and express proteins which disrupt the
cellular RNAi pathway, resulting in either induction or suppression. EBV induces the expression of the cellular miR-155 which
assists in the expansion of infected B-cells and promotes their
transformation whereas HIV-1 generates both RNA sequences
and proteins which suppresses the RNAi pathway. Indeed, HIV-1

Figure 5. Loss of Drosha increases viral replication. A) 293T cells were transfected with HTLV-1 pACH (5 mg) and 24 hours later were
transfected with siRNAs against Luciferase (150 nM), Drosha (50, 150, and 300 nM), DGCR8 (50, 150, 300 nM), and Ago2 (50, 150, 300 nM) or were
treated with 0.1, 1.0, or 2.5 mM Acriflavine (ACF). At 72 hours post-transfection, supernatants were collected and assessed for viral replication by RT
(reverse transcriptase) assay. Data was collected in triplicate from at least 2 independent experiments. B) 293T cells from panel A were assayed by
western blot for the efficiency of siRNA knockdown of the target proteins. b-Actin serves as a positive loading control.
doi:10.1371/journal.pone.0040662.g005
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Figure 6. Suppression of endogenous miRNAs dysregulated by HTLV-1. A) 293Ts were transfected with pACH.Tax (5 mg) and 24 hours later
were transfected with pGFP-Drosha (10 mg). Cells were collected 48 hours post transfection and were western blotted (50 mg) for IKK-b, BRM and bActin. B) 293T cells were transfected with Tax (5 mg) or antagomiRs (100 nM) targeting miR-199a-3p, miR-132, or Let7i. Cells were collected 72 hours
post transfection, and western blotted (50 mg) for IKK-b, p65, p50, GSK-3b, BRM, and b-Actin. Densitometry counts of western blots for each indicated
protein normalized to b-Actin, plotted as a percent change (measured as arbitrary counts) between antagomiR treated cells and 293T cells alone.
Densitometry counts were calculated using ImageJ.
doi:10.1371/journal.pone.0040662.g006

HTLV-1 gene expression is regulated not only by Tax, but also
by the viral protein Rex. Rex induces the expression of HTLV-1
structural proteins post-transcriptionally, by binding to the RxRE
(Rex-responsive element) on the U3 region of the HTLV-1 LTR
(long-terminal repeat) [81–83]. Recently, Rex has been shown to
suppress the RNAi pathway by interacting with cellular Dicer,
inhibiting the conversion of shRNA to siRNA [15]. As we have
shown that Drosha is downregulated not only with HTLV-1
infection, but specifically in the presence of Tax, therefore we
hypothesized that Tax could be interacting directly with Drosha.
Tax-transfected HeLa cells show distinct, punctate foci in the
nucleus when stained with antibodies against both Tax and
Drosha in independent experiments. We observed that Tax and
Drosha colocalize distinctly, however it is important to note that
this HTLV-1-dependent downregulation of Drosha is not completely efficient, and that there is still some endogenous Drosha
remaining in these cells. This is analogous and similar to the
colocalization of cellular Rb and Tax in cells (Figure 2D) as we
have previously shown that Tax binds directly to Rb and is a
necessary interaction for the subsequent degradation of Rb in vitro
[47]. We next demonstrated that Drosha can be found in complex
with Tax at the N-terminus, specifically at the region spanning aa
1–244. Within this N-terminal region of Tax, we observed two
potential motifs that could be utilized for this interaction, the Zinc
finger motif and the leucine-zipper-like region. The N-terminus of
Tax is most commonly known for the CREB (cAMP-responsive
element-binding)-transactivation domain where the transcription
factors p300/CBP, and p/CAF (p300/CBP-associated factor) bind
and promote viral transcription from the LTR [56]. We have
specifically shown the interaction of Drosha and Tax with an
immunoprecipitation of Drosha from Tax-expressing cells in the
presence of proteasome inhibitors. We indicate that this interaction is not seen when a cell is expressing the Tax mutant,
ACH.M22. Interestingly, the N-terminus portion of Tax is also
known to interact with the proteasome, therefore this dual binding
allows Tax to bring Drosha in close proximity with the proteasome
complex, resulting in the degradation of Drosha. This proteasomal
degradation is confirmed by a 50% recovery of total Drosha
PLoS ONE | www.plosone.org

protein levels in HTLV-1 infected cells when treated with
proteasome inhibitors PSI (cbz-ile-glu-(O-t-Bu)-ala-leucinal) and
ALLN (N-acetyl-leu-leu-norleucinal). These proteasome inhibitors
have also been well documented as anticancer and antiagiogenic
therapeutics. Furthermore, a number of colleagues in the field
have shown that proteasome inhibitors such as PS-341 or
bortezomib can in fact downregulate HTLV-1 levels, resulting in
a decrease of T-cell leukemia cells [84–88]. This is consistent with
our siDrosha and proteasome inhibitor data, where a drug/
peptide inhibitor can regulate miRNA machinery by increasing
proteins such as Drosha resulting in an increased host cellular
RNAi response against HTLV-1 activity.
Three large studies have recently examined the dysregulation of
cellular miRNAs in both HTLV-1 infected cell lines and ATLL
samples, resulting in surprisingly little overlap [67,89–91]. These
studies do however provide a large pool of upregulated and
downregulated cellular miRNAs from which to pull functional
data in the context of HTLV-1 infection. We show here, that in
the presence of Tax, endogenous Drosha is less functional and not
as efficient in processing miRNAs. Drosha efficiency, as measured
by the processing of endogenous miR326 as compared to overall
levels of transcript, was highest in the presence of N-terminal Tax
deletion mutants from residues 1–92. This again indicates that the
interaction between Tax, Drosha, and the proteasome occurs on
the N-terminal region of Tax.
We also show that in the absence of Drosha, HTLV-1 viral
replication increases by at least two-fold. The knockdown of
DGCR8 also resulted in a significant increase in HTLV-1
replication, suggesting a dysregulation of the microprocessing
complex. The downregulation of HTLV-1 replication with Ago2
knockdown was validated with a comparable downregulation
when cells were treated with the RISC inhibitor ACF.
We suggest that HTLV-1 dysregulates the RNAi pathway,
including up- and down-regulation of cellular miRNAs by
inhibiting the function of and degrading Drosha, resulting in a
modulation of tumor and viral suppressing cellular functions. One
miRNA upregulated in HTLV-1 infection, miR-146a, can be
activated by Tax through an NF-kB-dependent pathway. This
10
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in DMEM containing 10% FBS, 1% L-Glutamine, and 1%
streptomycin/penicillin (Quality Biological) at 37uC in 5% CO2.

miRNA, however, has been experimentally shown to both
interfere with HTLV-1 infected cell growth, as well as stimulate
infected cell growth upon overexpression [90]. Overexpression of
miR146a appears to favor the proliferation of an HTLV-1 infected
cell population, however this effect is not always reproducible [67].
Due to the nature of the control of miRNA production in HTLV-1
infection, it is not surprising to observe an increase in viral
replication in the absence of Drosha, due likely to the downregulation of a cellular miRNA that would otherwise suppress viral
replication. In order to investigate the control of miRNA
production in HTLV-1 cells, we analyzed the pool of published
downregulated miRNAs for those that target cellular proteins
known to interact with Tax and regulate transcription. Our
rationale here was that if HTLV-1 infection downregulates a
particular miRNA which targets a cellular protein necessary for
Tax transactivation, we could mimic this interaction by introducing an antagomiR into uninfected cells, therefore disabling the
endogenous miRNA and increasing protein expression. Based on
three recent studies which examined expression changes of cellular
miRNAs in HTLV-1 infected cell lines, we selected the
downregulated miRNAs, miR-199a, miR-132, and miR-Let7i
for further analysis [67,89–90,92]. In ovarian cancer cells, miR199a-3p has been shown to regulate IKK-b to affect NF-kB
activity as well as targeting the SWI/SNF subunit BRM in a
variety of human cancers [93–94]. Upon KSHV (Kaposi’s
sarcoma-associated herpesvirus) infection, as well as HSV-1
(herpes simplex virus-1) and HCMV (human cytomegalovirus)
infection, miR-132 is upregulated and regulates the transcriptional
co-activator p300 [95]. Following microbioal infection of Cryptosporidium parvum, miR-Let7i forms an inducible silencing complex
with the NF-kB p50 subunit [96]. Confirming this rationale in the
scope of HTLV-1 infection, we observed a increase in IKK-b and
BRM protein levels in the presence of Tax and an opposite effect
upon overexpression of functional Drosha. We observed an
increase in cellular levels of IKK-b, p65, p50, GSK-3b, and
BRM upon treatment with antagomiRs against the above
downregulated miRNAs as compared to cells alone, indicating
that the antagomiRs mimic the cellular protein expression seen in
Tax-expressing cells. Tax plays a major role in the activation of
cellular NF-kB, however, HTLV-1 infected cells also develop Taxindependent activation of NF-kB. This delicate balance between
activation and suppression of these cellular genes via the
manipulation of the RNAi pathway by HTLV-1 infection strongly
supports the notion that dysregulation of Drosha and other core
components of the RNAi machinery control the rate of infection
and T-cell transformation.

Antibodies and siRNA
Antibodies used for confocal microscopy are as follows: a-BRG1
(sc-10768), a-Rb (sc-74562), and a-GIT2 (sc-5416) were obtained
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), a-Drosha
(ab12286) was obtained from Abcam (Cambridge, MA), a-Tax
was generated in house, and AlexaFluor 488 Goat-anti-Rabbit
(A11008), AlexaFluor 660 Donkey-anti-Rabbit (A21083), and
AlexaFluor 568 Goat-anti-Mouse (A11004) were obtained from
Invitrogen (Carlsbad, CA). Antibodies used for western blotting
are as follows: a-Drosha (ab12286), a-DGCR8 (ab82876), a-Dicer
(ab14601), a-Ago2 (ab57113), and a-Ago1 (ab5070-100) from
Abcam (Cambridge, MA), a-Tax was generated in house, a-Actin
(sc-1615), a-Ubiquitin (sc-9133), a-p65 (sc-7151), a-p300 (sc-585),
and a-IKK-b (sc-7329) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and a-GSK-3b (27C10) was
obtained from Cell Signaling (Beverly, MA). SiRNA against
Luciferase (D-002050-01-20) was obtained from Thermo Scientific
(Rockford, IL) and siRNA against siDrosha (GS29102), siDGCR8
(GS54487), and siAgo2 (GS27161) were obtained from Qiagen
(Valencia, CA).

Electroporations/Transfections
293T cells were transfected with plasmid DNA according to
Attractene lipid reagent recommended protocols (Qiagen, Valencia, CA). Briefly, 293T cells at 2.56105 cells were plated in
DMEM +/+/+ (500 ml, with serum, with L-glutamine, with
penicillin/streptomycin) in a 24-well plate. A reaction mixture
containing pcDNA, pACH, pcTax, or pACH.M22 (0.1, 1.0, or
10 mg) plasmid DNA was incubated with Attractene reagent (3 ml)
in DMEM2/2/2 (100 ml, without serum, without L-glutamine,
without penicillin/streptomycin). The reaction mixture was
incubated for 20 min at 25uC and then added dropwise onto
the cells. Cells were collected 48 hours post-transfection. Lipid
transfections of pcTax, pACH, and siRNA were performed
according to Attractene and Lipofectamine RNAiMax (Invitrogen,
Carlsbad, CA) lipid reagent recommended protocols (Qiagen,
Valencia, CA). Briefly, 2.56105 cells were plated in DMEM +/+/+
(500 ml) in a 24-well plate. A reaction mixture containing ACH
DNA (5 mg) was incubated with Attractene reagent (3 ml) in
DMEM 2/2/2 (100 ml). The reaction mixture was incubated for
20 min at 25uC and then added dropwise onto the cells. At 24
hours post-transfection, a reaction mixture containing siLuc
(150 nM), siDrosha (50, 150, 300 nM), siDGCR8 (50, 150,
300 nM) or siAgo2 (50, 300 nM), was incubated with RNAiMax
reagent (1.5 ml). The reaction mixture was incubated for 20 min at
25uC and then added dropwise onto the cells. Lipid transfections
of the Tax expression vectors (Tax WT, TD1 (D1–37), TD55
(D55–92), TD99 (D99–142), TD150 (D150–198), TD254 (D254–
287), or TD319 (D319–353)) were performed in 6-well plates
according to Lipofectamine 2000 recommended protocols (Invitrogen, Carlsbad, CA). Lipid transfections of pACH.Tax (5 mg),
pACH.M22 (5 mg), and pGFP-Drosha (10 mg) were performed
with Attractene as indicated above. The wild-type pEGFPC1_Drosha expression vector was kindly provided by Dr. Bharat
Ramratnam (Warren Alpert Medical School, Brown University,
Providence, RI).

Materials and Methods
Cell Culture
Uninfected T-cell lines H9, Jurkat, and CEM cells as well as
HTLV-1 infected, Tax-positive T-cell lines C81, MT2, and MT4
were obtained from the NIH AIDS Research and Reference
Reagent Program. HTLV-1 infected, Tax-negative cell lines were
a generous gift from Dr. Cynthia Pise-Masison (NCI/NIH,
Bethesda, MD). HeLa cervical carcinoma cell line and 293T
endothelial kidney cells were obtained from ATCC (Manassas,
VA). Primary CD4+ T-cells (#2W-200, Lonza, Allendale, NJ)
infection were a generous gift from Dr. Pooja Jain (Drexel
University College of Medicine, Doylestown, PA). Suspension cell
lines were maintained in RPM1-1640 media containing 10% FBS,
1% L-glutamine, and 1% streptomycin/penicillin (Quality Biological) at 37uC in 5% CO2. Adherent cell lines were maintained
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Confocal Microscopy
HeLa cells were grown on coverslips for 48 hrs post pcTax
transfection. Cells were fixed with 4% paraformaldehyde for one
hour. Cells were permeabilized with Triton X-100 in PBS (0.5%)
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for 20 min and washed with PBS without Ca2+ and Mg2+. Cells
were blocked at 25uC for 10 min with Goat Serum (3%) in PBS
without Ca2+ and Mg2+. Cells were incubated with primary
antibody (1:200) in Goat Serum (3%) for one hour, in the dark, at
37uC. Cells were washed 36 with PBS without Ca2+ and Mg2+
and secondary antibodies were added (1:50) in Goat Serum (3%)
for one hour, in the dark, at 37u. Cells were washed 36 with PBS
without Ca2+ and Mg2+ and a sufficient volume of DAPI working
solution was added to completely cover the sample, incubating for
2–10 min, in the dark, at 25uC. Coverslips were washed to remove
excess DAPI and mounted onto a slide with Fluoromount G
(10 ml, Southern Biotech, Birmingham, AL). Cells were imaged
with a Zeiss LSM 710 Confocal System (George Washington
University, Center for Microscopy and Image Analysis).

Total RNA was isolated from the indicated cell types using the
TRIzol protocol (Invitrogen, Carlsbad, CA). From total RNA, 2 ml
of RNA was used for the cDNA synthesis reaction using iScript
(Bio-Rad, Hercules, CA). The newly synthesized cDNA was used
as the template for a PCR reaction for Drosha (TGCAACTGGTAGCCACAGAG, ACACTGCTGAAGCTGGGATT) and
GAPDH
(GGAAGGTGAAGGTCGGAGTCAA,
CCTTGACGGTGCCATGGAAT). Expression of miR326 was
determined by the quantiMiR PCR kit (SBI, Mountainview, CA)
using
the
miR326
detection
(sense)
primer:
CCTCTGGGCCCTTCCTCCAG. Primary transcripts encoding
miR326 were detected by RT-qPCR (CACCAACATCCTAGCCCAAACG, AAGTGAGAACCGGGAAGCAAG).

Western Blotting

Immunoprecipitation

Cells were collected from culture and spun at 1,800 rpm, for
5 min, at 4uC, and pellets were washed twice with phosphate
buffered saline (PBS) without Ca2+ and Mg2+ (Quality Biological). Cell pellets were resuspended in lysis buffer (50 mM TrisHCl, pH 7.5, 120 mM NaCl, 5 mM EDTA, 0.5% NP-40,
50 mM NaF, 0.2 mM Na3VO4, 1 mM DTT, one complete
protease cocktail tablet/50 mL) and incubated on ice for
20 min, with gentle vortexing every 5 min. Cell lysates were
centrifuged at 10,000 rpm for 10 min. Protein concentrations
were determined using Bradford protein assay (Bio-Rad, Hercules,
CA). Cell extracts were loaded (50–75 mg) on a 4–20% SDSPAGE gel, run at 200 V, and transferred onto nitrocellulose
membranes. Membranes were blocked with PBS containing 0.1%
Tween-20 and milk (5%), and incubated overnight at 4uC with the
appropriate primary antibody. Membranes were incubated with
the appropriate secondary antibody and developed next day.
Whole cell extracts from CD4+ primary T-cells were prepared
using M-PER Mammalian Protein Extraction Reagent (Pierce,
USA). Cell debris was cleared from the lysates by centrifugation
(5 min, 14,000 g). Protein concentrations were determined using
Bradford protein assay (Bio-Rad, Hercules, CA). Cell lysates were
resolved by SDS-PAGE and transferred to a PVDF membrane.
The blots were blocked for 1 h with Odyssey blocking buffer
(Licor, Lincoln, NE) and rinsed with PBST (PBS +0.05% Tween20), once for 10 min and twice for 5 min. The membranes were
then incubated with either a-Drosha (1:1000) or a-Actin (1:2000)
monoclonal antibodies (Abcam, Cambridge, MA), for 2 hours at
room temperature, rinsed with PBST (once for 10 min and twice
for 5 min), and incubated for 1 hour with an a-rabbit and a-mouse
secondary antibody (Licor, Lincoln, USA) conjugated to IRDy800
and IRDy680 respectively. Signals were detected by Licor Pearl
Pulse Imager. Densitometry was performed using ImageJ software
(Wayne Rasband, NIH, USA).

Cell extracts from 293T cells alone, cells transfected with
pACH.Tax (5 mg), or pACH.M22 (5 mg) were collected as
described above. Whole cell extracts (,1 mg) were incubated
overnight, rotating, at 4uC with a-IgG, a-Drosha, or a-Tax. The
next day, 50 ml of a 30% slurry of Protein A+G beads
(Calbiochem, Rockland, MA) was added to the IPs and incubated
for two hrs, rotating, at 4uC. The IPs were spun briefly and beads
were washed 16 with TNE150+0.1% NP-40, followed by a 16
wash with TNE50+0.1% NP-40. Proteins were eluted off of the
beads with Laemmli buffer, run on a gel, and western blotted for
both Drosha and Ubiquitin.

RT-PCR

Reverse Transcriptase Assay
Supernatants were collected at indicated time points to test for
the presence of virus. Viral supernatants (10 mL) were incubated in
a 96-well plate with a RT reaction mixture containing 16 RT
buffer (50 mM Tris–HCl, 1 mM DTT, 5 mM MgCl2, and
20 mM KCl), 0.1% Triton-X100, poly(A) (1 U/mL), poly d(T)
(1 U/mL), and [3H]TTP. The mixture was incubated overnight at
37uC, 5 ml of the reaction mix was spotted on a DEAE Filtermat
paper, washed four times with 5% Na2HPO4, three times with
water, and then dried completely. RT activity was measured in a
Betaplate counter (Wallac, Gaithersburg, MD). Data is shown as
cpms (counts per minute).

GST-Pulldown
HeLa whole cell extracts (1 mg) were prepared and incubated
with 10 ug of the following GST-Tax constructs bound to
glutathione-sepharose beads: GST-Tax wildtype, GST-Tax 1–
244 (N-terminus), GST-Tax 244–336 (C-terminus), and GST-Tax
288–353. Extracts were brought up to 500 ml in TNE50+0.1% NP40 (100 mM Tris-HCl, pH 7.5; 50 mM NaCl; 1 mM EDTA;
0.1% NP-40) buffer and incubated overnight at 4uC with rotation.
The following day, samples were spun and washed twice with
TNE150+0.1% NP-40 (100 mM Tris, pH 8.0; 300 mM NaCl;
1 mM EDTA, 0.1% NP-40) buffer and 16 with TNE50+0.1%
NP-40 to remove nonspecifically bound proteins. Samples were
loaded and run on a 4–20% Tris-Glycine SDS-PAGE gel and
subjected to Western blotting for the presence of Drosha.

Proteasome Inhibitor Treatments
C81 HTLV-1 infected cells were plated at a density of 16106
cells/well in a 12-well plate. Cells were treated with three
concentrations (0.1, 1.0, and 10 mM) of the proteasome inhibitors
ALLN (208750), and PSI (539160) obtained from EMD4Biosciences (San Diego, CA). Cells were collected 48 hours post
treatment, washed, lysed, and Western blotted for Drosha and bActin. Alternatively, 293T cells were treated with 10 mM of PSI
and 24 hours later were transfected with the indicated expression
vectors (pACH.Tax or pACH.M22). Cells were collected, washed,
lysed, and prepared for immunoprecipitation.
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AntagomiR Experiments
AntagomiRs were obtained from Qiagen as follows: miScript
miRNA inhibitor Anti-hsa-let-7i (Catalog # MIN0000415), Antihsa-miR-199a-3p (Catalog # MIN0000232), and Anti-hsa-miR132 (Catalog #MIN0000426). AntagomiRs were transfected into
293T cells using Attractene as described above. Briefly, 293T cells
were plated at 16105 cells/well in a 6 well plate. AntagomiRs were
12
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incubated in DMEM 2/2/2(100 ml, 100 nM) with Attractene
(1.5 ml) at 25uC for 20 min. The transfection mix was added to the
cells dropwise. Cells were collected at 72 hrs post transfection,
lysed, and extracts (50 mg) were loaded onto a 4–20% SDS-PAGE
gel. Western blots were performed using antibodies against p65,
p300, IKK-b, and b-Actin. Densitometry was performed using
ImageJ software (Wayne Rasband, NIH, USA).
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